发明名称 |
COMPOSITION AND METHOD FOR INHIBITION OF JAK PATHWAY |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide compounds and methods in the treatment of conditions in which inhibition of JAK kinases, particularly JAK3, a family of cytoplasmic protein tyrosine kinases or modulation of the JAK pathway can be therapeutically useful. <P>SOLUTION: A pharmaceutical composition for inhibiting the activity of JAK kinase contains 5-Fluoro-N2-(4-methyl-3-propionylaminosulfonylphenyl)-N4-[4-(prop-2-ynyloxy)phenyl]-2,4-pyrimidinediamine or a solvate or pharmaceutically acceptable salt thereof. <P>COPYRIGHT: (C)2013,JPO&INPIT |
申请公布号 |
JP2012229217(A) |
申请公布日期 |
2012.11.22 |
申请号 |
JP20120129760 |
申请日期 |
2012.06.07 |
申请人 |
RIGEL PHARMACEUTICALS INC |
发明人 |
LI HUI;THOTA SAMBAIAH;CARROLL DAVID;ARGADE ANKUSH;TSO KIN;SRAN ARVINDER;CLOUGH JEFFREY;KEIM HOLGER;BHAMIDIPATI SOMASEKHAR;TAYLOR VANESSA;COOPER ROBIN;SINGH RAJINDER;WONG BRIAN |
分类号 |
C07D239/48;A61K31/505;A61P37/06;A61P43/00 |
主分类号 |
C07D239/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|